'Who will opt for vaccine...': Congress questions approval, slams govt

Video Credit: HT Digital Content
Published on January 5, 2021 - Duration: 03:25s

'Who will opt for vaccine...': Congress questions approval, slams govt

Congress leader Manish Tewari alleged that the union government has 'politically misused pandemic in its entirety'.

Tewari also slammed the Centre over the grant of approval to Bharat Biotech's Covid vaccine.

The congress leader, however, did not name the Hyderabad-based company.

On Sunday, DCGI approved the Oxford University-AstraZeneca Covid-19 vaccine, Covishield, and Bharat Biotech’s Covaxin for restricted emergency use.

Many other opposition leaders including Jairam Ramesh, Shashi Tharoor and Akhilesh Yadav have voiced against the approval to Bharat Biotech's vaccine.

Amid the political slugfest, Bharat Biotech chairperson and managing director, Krishna Ella, hit out at the critics.

The company also asked for a weeks' time to prove its efficacy with evidence.


You are here


💡 newsR Knowledge: Other News Mentions


Indian National Congress

Political party in India
Though the West Bengal assembly elections started on March 27, senior Congress leader Rahul Gandhi would campaign in the state for the first time on Wednesday...
Credit: IndiaTimes - Published 17 hours ago

Congress leader Rahul Gandhi on Monday asked Prime Minister Modi to ensure that everyone in the country gets the coronavirus vaccine and advised him to stop..
Credit: IndiaTimes - Published 2 days ago

Batting for coronavirus vaccine for all, Congress leader Rahul Gandhi on Monday said it is the need of the country as everyone has the right to a safe life. He..
Credit: IndiaTimes - Published 2 days ago

Congress general secretary Priyanka Gandhi Vadra wrote to Education Minister Ramesh Pokhriyal Nishankon Sunday seeking cancellation of the CBSE Board exams,..
Credit: IndiaTimes - Published 3 days ago

In an apparent dig at Prime Minister Narendra Modi, Congress leader Rahul Gandhi tweeted in Hindi, "No control over coronavirus, not enough vaccines, no..
Credit: IndiaTimes - Published 3 days ago



COVID-19

Disease caused by severe acute respiratory syndrome coronavirus 2
The Central Board of Secondary Education (CBSE) on Wednesday postponed class 12 board exams and cancelled class X board exams due to the persisting Covid-19..
Credit: IndiaTimes - Published 1 hour ago


Dr Reddy's Laboratories said on Tuesday it has received permission from the Drug Controller General of India (DCGI) to import the Sputnik vaccine into India for..
Credit: IndiaTimes - Published 1 day ago

Following the recommendation of the Drug Controller General of India (DGCI)'s subject expert committee, Russia's anti-Covid vaccine Sputnik V now awaits final..
Credit: IndiaTimes - Published 1 day ago

Amid concerns about the need to step up Covid-19 vaccination, India is soon expected to get its third shot against the infection with the drug regulator’s..
Credit: IndiaTimes - Published 2 days ago

Russia on Monday hoped that the Drug Controller General of India (DCGI) will soon complete the approval process for the Sputnik-V coronavirus vaccine after it..
Credit: IndiaTimes - Published 2 days ago


AstraZeneca

British-Swedish pharmaceutical company
The safety committee of the European Medicines Agency (EMA) has asked those receiving the AstraZeneca vaccine (called Covishield in India) and medical..
Credit: IndiaTimes - Published 3 days ago

A former AstraZeneca board member has told Sky News that she thinks the company has been unfairly criticised over its handling of the vaccine rollout.
3 days ago • Sky News


Related videos from verified sources

‘Indians are not guinea pigs’: Manish Tewari attacks govt over Covaxin approval 01:40
Video credit: HT Digital Content - Published on January 13, 2021 

Covid vaccine: Congress minister's appeal to Modi govt after Jan 16 launch move 03:58
Video credit: HT Digital Content - Published on January 9, 2021 

Covid vaccine: Impotency fear to 'premature' approval, Opposition slams govt 05:14
Video credit: HT Digital Content - Published on January 3, 2021 

You might like